✦ LIBER ✦

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

✍ Scribed by Shelby D. Reed; Jasmina I. Radeva; Kevin P. Weinfurt; John J.V. McMurray; Marc A. Pfeffer; Eric J. Velazquez; Jennifer S. Allsbrook; Leah E. Masselink; Mary Ann Sellers; Robert M. Califf; Kevin A. Schulman

Book ID: 116189866
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 390 KB
Volume: 150
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2004.08.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Usefulness of Beta Blockers in High-Risk

Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)

✍ Robert M. Califf; Yuliya Lokhnygina; Eric J. Velazquez; John J.V. McMurray; Jeff 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 617 KB

Newly diagnosed and previously known dia

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: The VALsartan in Acute myocardial iNfarcTion (VALIANT) trial

✍ D. Aguilar; S.D. Solomon; L. Køber 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Relation of Mortality to Failure to Pres

Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)

✍ Jonathan P. Piccini; Patrick M. Hranitzky; Rakhi Kilaru; Jean-Lucien Rouleau; Ha 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Chronic obstructive pulmonary disease is

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

✍ Hawkins, Nathaniel M.; Huang, Zhen; Pieper, Karen S.; Solomon, Scott D.; Kober, 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 117 KB

Use of resources, quality of life, and c

Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)

✍ Alejandro Barbagelata; Robert M Califf; Elena B Sgarbossa; Shaun G Goodman; Davi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Clinical Outcomes, Resource Use, and Cos

Clinical Outcomes, Resource Use, and Costs at 1 Year in Patients with Acute Coronary Syndrome Undergoing PCI: Results from the Multinational APTOR Registry

✍ AMEET BAKHAI; JEAN FERRIERES; ANDRES IÑIGUEZ; MAGALI SARTRAL; MARK BELGER; CLAUD 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB